Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.

Autor:	Kosiborod, M. N.1 mkosiborod@saint-lukes.org, Petrie, M. C.2, Borlaug, B. A.3, Butler, J.4,5, Davies, M. J.6, Hovingh, G. K.7, Kitzman, D. W.8, Møller, D. V.7, Treppendahl, M. B.7, Verma, S.9, Jensen, T. J.7, Liisberg, K.7, Lindegaard, M. L.7, Abhayaratna, W.10, Ben-Gal, T.11, Ahmed, F. Z.12, Chopra, V.13, Ezekowitz, J. A.14, Fu, M.15, Ito, H.16
Zdroj:	New England Journal of Medicine. 4/18/2024, Vol. 390 Issue 15, p1394-1407. 14p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu